EW Healthcare Partners, L.P.'s Form 4 filing
EyePoint, Inc.EYPT · filed Sep 1, 2023
- Accession no.
- 0000899243-23-018636
- Filed
- Sep 1, 2023, 4:51 PM ET
- Trade date
- Aug 30-31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $1.47M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| EW Healthcare Partners, L.P.CIK 0001612343 | 10% Owner, Other: See footnotes 1 and 6 |
| Essex Woodlands Fund IX-GP, L.P.CIK 0001652285 | 10% Owner |
| Essex Woodlands IX, LLCCIK 0001652286 | 10% Owner |
| EW Healthcare Partners-A, L.P.CIK 0001736240 | 10% Owner, Other: See footnotes 1 and 6 |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −60,649 | $10.92F2 | −$662,432.64 | 3,589,743 | Indirect | |
| Aug 30, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −327 | $11.36F3 | −$3,714.56 | 3,589,416 | Indirect | |
| Aug 31, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −71,478 | $10.17F4 | −$726,723.97 | 3,517,938 | Indirect | |
| Aug 31, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −7,017 | $11.02F5 | −$77,337.16 | 3,510,921 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.32 to $11.29. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $11.35 to $11.37. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $9.83 to $10.76. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.84 to $11.23. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.